Expanding the Role of Long-Acting Injectable ART

Expanding the Role of Long-Acting Injectable ART is organized by Prime Education, LLC.

Release Date: November 15, 2023
Expiration Date: November 14, 2024

Description:
The advent of long-acting injectable antiretrovirals presents new ways to support individuals with multidrug-resistant HIV, as well as those facing barriers to taking daily oral medications.

Take this 15-minute quiz to test your knowledge and deepen your skills in personalizing HIV treatment to meet the unique needs of your patients.

For information on how this activity fits in the Royal College of Physicians and Surgeons of Canada Maintenance of Certification (MOC) Program, please visit the Royal Colleges.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS).

International learners are encouraged to consult with their local boards and/or agencies for equivalency status.

Learning Objectives:
• Apply recent guideline updates as well as clinical trials and real-world evidence in the development of individualized HIV treatment plans
• Compare the safety, efficacy, and pharmacologic profiles of antiretroviral agents with novel mechanisms of action and routes of administration
• Integrate the latest data and expert best practices to tailor ART selection for diverse patients facing unique challenges such as comorbid conditions, multidrug resistance, and factors impeding adherence

0.3 Contact Hours | 0.3 AMA PRA Category 1 Credit™ | 0.3 CE | 0.3 CNE | 0.3 CPE | 0.3 IPCE | 0.0 CEUs | 0.3 MOC